Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa

Neurology

Volumn 67, Issue 6, 2006, Pages 1053-1055

  Sugg, R M ^a   Gonzales, N R ^a   Matherne, D E ^a   Ribo, M ^a   Shaltoni, H M ^a   Baraniuk, S ^b   Noser, E A ^a   Grotta, J C ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A; TROPONIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ENZYME ASSAY; FEMALE; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; CEREBRAL HEMORRHAGE; ELECTROCARDIOGRAPHY; FACTOR VII; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECOMBINANT PROTEINS; TIME FACTORS; TROPONIN;

EID: 33749019450     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000239154.51331.c4     Document Type: Article

References (10)

1. Qureshi AI, Suri MR, Ostrow PT, et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344:1450-1460.
2. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1-5.
3. Broderick JP, Adams HP Jr., Barsan W, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30:905-915.
4. Mayer SA, Brun NC, Broderick J, et al. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005;36:74-79.
5. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-785.
6. O'Connell KA, Wood JJ, Wise RP, Lozier JN, Braun MM. Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006;295:293-298.
7. Apak I, Iltumur K, Tamam Y, Kaya N. Serum cardiac troponin T levels as an indicator of myocardial injury in ischemic and hemorrhagic stroke patients. Tohoku J Exp Med 2005;205:93-101.
8. Ay H, Arsava EM, Saribas O. Creatine kinase-MB elevation after stroke is not cardiac in origin: comparison with troponin T levels. Stroke 2002;33:286-289.
9. NovoNordisk. NovoSeven (package insert). 2005. Available at: http://www.us.novoseven.com/content/us_vers/downloads/0804Novosevenpl.pdf
10. Hough RE, Hampton KK, Preston FE, Channer KS, West J, Makris M. Recombinant VIIa concentrate in the management of bleeding following prothrombin complex concentrate-related myocardial infarction in patients with haemophilia and inhibitors. Br J Haematol 2000;111:974-979.